https://thescriptpad.com/articles/cms-extends-hospice-home-health-enrollment-moratoria-medical-director-rule-van-nuys-23-hospices.htmlThe Script Paden2026-11-13T10:30:00-05:00One Van Nuys Address Lists 23 Hospices. CMS Is Keeping New Ones Out of Medicare for Six More Months. https://thescriptpad.com/articles/cdc-mmwr-glp-1-use-9-8-percent-adults-compounded-22-percent-modified-dosing-44-percent.htmlThe Script Paden2026-11-13T10:20:00-05:00Two in Five GLP-1 Users Skipped, Cut or Delayed Doses in 2025, a CDC Survey Finds https://thescriptpad.com/articles/fda-17-discontinued-drugs-not-withdrawn-for-safety-byetta-dibenzyline-vyndaqel-generics-count.htmlThe Script Paden2026-11-13T10:10:00-05:00Byetta, Dibenzyline and 15 Other Drugs Are Off the Market. FDA Says Safety Was Not the Reason. https://thescriptpad.com/articles/dea-2026-stimulant-quota-increase-amphetamine-methylphenidate-2027-proposed-quotas.htmlThe Script Paden2026-11-12T10:30:00-05:00DEA Raises ADHD Stimulant Production Limits for the Third Straight Fall as Shortages Persist https://thescriptpad.com/articles/oveporexton-orzeyful-schedule-iv-99-days-dea-scheduling-timeline.htmlThe Script Paden2026-11-12T10:20:00-05:00Narcolepsy's First Orexin Agonist Lands in Schedule IV, 99 Days After FDA Approval https://thescriptpad.com/articles/medicare-negotiation-final-rule-subcutaneous-hyaluronidase-biologics-same-drug-2029.htmlThe Script Paden2026-11-12T10:10:00-05:00Medicare's Final Negotiation Rule Counts Subcutaneous Versions of Infused Biologics as the Same Drug https://thescriptpad.com/articles/fda-proposes-reclassify-oncology-ihc-companion-diagnostics-class-ii-510k-pd-l1-her2.htmlThe Script Paden2026-11-12T10:00:00-05:00FDA Proposes Moving Oncology IHC Companion Tests From Premarket Approval to 510(k) Clearance https://thescriptpad.com/articles/ama-interim-meeting-2026-ai-licensure-downcoding-emergency-department-policies.htmlThe Script Paden2026-11-11T10:30:00-05:00What the AMA's House of Delegates Decided in Orlando, From AI Licensure to Downcoded Claims